Robert Manges
Hematology | Oncology
11050 Parkview Circle Dr
Fort Wayne, IN 46845
Fort Wayne, IN 46845
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Safety and efficacy of durvalumab with R-CHOP or R2-CHOP in untreated, high-risk DLBCL: a phase 2, open-label trial.
Journal: International journal of hematology
Published: August 17, 2021
A phase 2 safety study of accelerated elotuzumab infusion, over less than 1 h, in combination with lenalidomide and dexamethasone, in patients with multiple myeloma.
Journal: American journal of hematology
Published: December 09, 2016
Pharmacokinetics and Safety of Elotuzumab Combined With Lenalidomide and Dexamethasone in Patients With Multiple Myeloma and Various Levels of Renal Impairment: Results of a Phase Ib Study.
Journal: Clinical lymphoma, myeloma & leukemia
Published: September 22, 2015
Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 10, 2015
A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma.
Journal: British journal of haematology
Published: November 05, 2012
Showing 1-5 of 5
Last Updated: 09/26/2026